Clinical Trial Update: Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2 [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interleukin-2 for treating childhood acute myeloid leukemia. The current status of the study is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Leukemia | Phase 3 | Status: UNKNOWN